Risk of gastrointestinal perforation in patients with rheumatic diseases exposed to <scp>JAK</scp> inhibitors versus adalimumab: a nationwide cohort study: comment on the article by Hoisnard et al

Jing‐jin HuYang‐yang LuJun‐kang ZhaoDan MaLi‐yun ZhangJames Cheng‐Chung Wei2026-02-052026-02-052025-03-0310.1002/art.43117https://scholars.csmu.edu.tw/handle/123456789/5176Risk of gastrointestinal perforation in patients with rheumatic diseases exposed to <scp>JAK</scp> inhibitors versus adalimumab: a nationwide cohort study: comment on the article by Hoisnard et aljournal-article